Autolus Therapeutics (AUTL) EBIT Margin (2017 - 2026)
Autolus Therapeutics' EBIT Margin came in at -95.95% for Q2 2026, up 196.63 percentage points from -292.58% a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) EBIT Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Autolus Therapeutics reported EBIT Margin of -222.26%, up 680.38 percentage points year-over-year; for FY2025, it was -358.87%, up 2026.76 percentage points from FY2024.
- EBIT Margin carries a five-year change of +9445.50 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -2385.63% in FY2024 (+8197.47 pp), -10583.10% in FY2023 (-8328.25 pp), -2254.84% in FY2022 (+3798.81 pp) and -6053.65% in FY2021 (+3750.73 pp).
- The Q2 2026 figure represents the highest quarterly EBIT Margin in data going back to Q1 2018.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2025 (a gain of 261301.65 percentage points), and the weakest in Q3 2021 (a drop of 12246.39 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Autolus Therapeutics | 660.38 Mn | -663.71 Mn | 25.22 Mn | -95.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -95.95% |
| Dec 31, 2025 | -298.35% |
| Sep 30, 2025 | -337.93% |
| Jun 30, 2025 | -292.58% |
| Mar 31, 2025 | -726.34% |
| Dec 31, 2024 | -261,600.00% |
| Mar 31, 2024 | -384.07% |
| Sep 30, 2023 | -10,567.73% |
| Mar 31, 2023 | -3,030.03% |
| Dec 31, 2022 | -304.58% |
| Sep 30, 2022 | -1,576.49% |
| Mar 31, 2022 | -21,798.80% |
| Dec 31, 2021 | -12,833.33% |
| Sep 30, 2021 | -17,099.58% |
| Jun 30, 2021 | -2,293.19% |
| Mar 31, 2021 | -14,822.30% |
| Dec 31, 2020 | -23,200.98% |
| Sep 30, 2020 | -4,853.18% |
| Jun 30, 2020 | -13,496.25% |
| Mar 31, 2020 | -11,409.17% |
API Access
Autolus Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();